Mu opioid receptor mRNA expression, binding, and functional coupling to G‐proteins in human epileptic hippocampus

Mu opioid receptors (MOR) are known to be involved in seizure activity. The main goal of the present study was to characterize the MOR mRNA expression, binding, as well as G protein activation mediated by these receptors in epileptic hippocampus of patients with pharmacoresistant mesial temporal lobe epilepsy (TLE). In contrast with autopsy samples, hippocampus obtained from patients with mesial TLE demonstrated enhanced MOR mRNA expression (116%). Saturation binding experiments revealed significantly higher (60%) Bmax values for the mesial TLE group, whereas the Kd values were not statistically different. Although mesial TLE group demonstrated high levels of basal binding for the G proteins (136%), DAMGO‐stimulated [35S]GTPγS binding did not demonstrate significant alterations. In conclusion, our present data provide strong evidence that the epileptic hippocampus of patients with pharmacoresistant mesial TLE presents significant alterations in MOR. Such changes may represent adaptive mechanisms to compensate for other as yet unknown alterations. © 2010 Wiley Periodicals, Inc.

[1]  J. Kraus,et al.  Transcriptional Regulation of the Human μ-Opioid Receptor Gene by Interleukin-6 , 2004, Molecular Pharmacology.

[2]  Alexander Hammers,et al.  Upregulation of opioid receptor binding following spontaneous epileptic seizures. , 2007, Brain : a journal of neurology.

[3]  D. Fujikawa,et al.  Prolonged seizures and cellular injury: Understanding the connection , 2005, Epilepsy & Behavior.

[4]  A. Herz,et al.  Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. , 1988, Molecular pharmacology.

[5]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[6]  A. Tripathi,et al.  Expression of δ- and μ-opioid receptors in the ventricular and subventricular zones of the developing human neocortex , 2008, Neuroscience Research.

[7]  Stefan Platzer,et al.  Autoradiographic distribution of μ-, δ- and κ1-opioid stimulated [35S]guanylyl-5′-O-(γ-thio)-triphosphate binding in human frontal cortex and cerebellum , 2000, Neuroscience Letters.

[8]  J. Engel,et al.  Effects of chronic naloxone pretreatment on amygdaloid kindling in rats , 1991, Epilepsy Research.

[9]  Alan A. Wilson,et al.  Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.

[10]  R. Spanagel,et al.  Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum. , 2000, Neuroscience letters.

[11]  Y. Wong,et al.  Activation of Type II Adenylyl Cyclase by the Cloned μ‐Opioid Receptor: Coupling to Multiple G Proteins , 1995, Journal of neurochemistry.

[12]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .

[13]  S. Orozco-Suárez,et al.  Temporal lobe epilepsy causes selective changes in mu opioid and nociceptin receptor binding and functional coupling to G-proteins in human temporal neocortex , 2009, Neurobiology of Disease.

[14]  A. Yalçın.  Quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress. , 2004, Acta biochimica Polonica.

[15]  J. Peltola,et al.  Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy , 2009, Journal of Neurology.

[16]  P. Escribá,et al.  Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[17]  J. L. Gordillo,et al.  Absolute and relative predictor values of some non-invasive and invasive studies for the outcome of anterior temporal lobectomy. , 2000, Archives of medical research.

[18]  J. García-Sevilla,et al.  Increased density of μ-opioid receptors in the postmortem brain of suicide victims , 1995, Brain Research.

[19]  R. M. Joy,et al.  Modification of kindled amygdaloid seizures by opiate agonists and antagonists. , 1984, The Journal of pharmacology and experimental therapeutics.

[20]  A. Herz,et al.  Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. , 1990, Molecular pharmacology.

[21]  W. Zieglgänsberger,et al.  Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Scheer,et al.  Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation. , 1997, Journal of receptor and signal transduction research.

[23]  A. Regec,et al.  Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. , 2005, Brain research. Molecular brain research.

[24]  C. Chavkin,et al.  Changes in Hippocampal Circuitry after Pilocarpine-Induced Seizures as Revealed by Opioid Receptor Distribution and Activation , 1997, The Journal of Neuroscience.

[25]  J. Engel,et al.  Characterization of mu opioid receptor binding during amygdala kindling in rats and effects of chronic naloxone pretreatment: an autoradiographic study , 1993, Epilepsy Research.

[26]  Anatoly Dritschilo,et al.  Transcriptional Repression by Binding of Poly(ADP-ribose) Polymerase to Promoter Sequences* , 2002, The Journal of Biological Chemistry.

[27]  N. Maidment,et al.  Amygdala Kindling Modifies Extracellular Opioid Peptide Content in Rat Hippocampus Measured by Microdialysis , 1997, Journal of neurochemistry.

[28]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[29]  P. Escribá,et al.  Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims , 2004, Neuropsychopharmacology.

[30]  Tadashi Yoshida,et al.  Positive Transcriptional Regulation of the Human μ Opioid Receptor Gene by Poly(ADP-ribose) Polymerase-1 and Increase of Its DNA Binding Affinity Based on Polymorphism of G−172 → T* , 2009, The Journal of Biological Chemistry.

[31]  G. Tóth,et al.  Met5‐enkephalin‐Arg 6‐Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain , 1997, Journal of neuroscience research.

[32]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[33]  F. Tortella,et al.  Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. , 1987, The Journal of pharmacology and experimental therapeutics.

[34]  R. Nicoll,et al.  Enkephalin hyperpolarizes interneurones in the rat hippocampus. , 1988, The Journal of physiology.

[35]  J. Guimón,et al.  Effects of Age, Postmortem Delay and Storage Time on Receptor-mediated Activation of G-proteins in Human Brain , 2002, Neuropsychopharmacology.

[36]  R. S. Sloviter,et al.  The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy , 1994, Annals of neurology.

[37]  S. Murphy,et al.  Functional receptors for neurotransmitters on astroglial cells , 1987, Neuroscience.